CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

The Competition and Markets Authority (CMA) has today issued a statement clarifying that certain types of engagements between competing drug firms working on ‘combination therapies’ will not be prioritized for investigation – making it easier for drug firms to work together to develop vital treatments for use in the NHS.

Dozens of Deaths Show Risks of Injecting Sedatives Into People Restrained by Police

The practice of giving sedatives to people detained by police spread quietly across the nation over the last 15 years, built on questionable science and

April 28, 2024

Kernel’s Revolutionary Neuroimaging Technology, Flow1, Validated in Published Feasibility Study on Measuring Psychedelic Effects | Psychedelic Invest

Kernel, a leader in non-invasive neuroimaging, announces the publication of their study “Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS,”

July 20, 2023

Bristol Myers joins AstraZeneca in agreeing to drug price negotiation terms ahead of first deadline

Pharma companies are now reluctantly agreeing to participate in the Center for Medicare and Medicaid Services’ first round of negotiations for 10 drugs. Ahead of

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.